Aquestive Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:AQST Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
26 Nov 24	SellUS$214	Cassie Jung	Individual		44	US$4.87

Insider Trading Volume

Insider Buying: AQST insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of AQST?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	4,640,759	5.09%
VC/PE Firms	5,555,555	6.09%
General Public	36,620,749	40.2%
Institutions	44,361,130	48.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 36.6%.

Top Shareholders

Top 25 shareholders own 52% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.8%	Bratton Capital Management, L.P.	9,810,958	US$30.7m	0%	100.0%
6.39%	BlackRock, Inc.	5,823,077	US$18.2m	6.75%	no data
6.09%	VR Adviser, LLC	5,555,555	US$17.4m	0%	0.88%
4.68%	The Vanguard Group, Inc.	4,263,796	US$13.3m	0.85%	no data
3.03%	Franklin Resources, Inc.	2,766,542	US$8.7m	-3.07%	no data
3.02%	Armistice Capital LLC	2,750,000	US$8.6m	0%	0.2%
1.97%	BioImpact Capital LLC	1,796,750	US$5.6m	0%	0.99%
1.83%	Geode Capital Management, LLC	1,667,515	US$5.2m	5.74%	no data
1.64%	State Street Global Advisors, Inc.	1,496,739	US$4.7m	52.1%	no data
1.52%	Daniel Barber	1,384,107	US$4.3m	0%	no data
1.34%	CHI Advisors LLC	1,225,000	US$3.8m	7.46%	1.77%
1.08%	Alexander Schobel	984,476	US$3.1m	0%	no data
1.01%	Janney Montgomery Scott LLC, Asset Management Arm	923,285	US$2.9m	4.86%	0.01%
0.96%	Citadel Advisors LLC	871,833	US$2.7m	420%	no data
0.9%	Woodline Partners LP	816,252	US$2.6m	35.8%	0.02%
0.83%	Invesco Capital Management LLC	754,651	US$2.4m	1,240%	no data
0.78%	Essex Investment Management Company, LLC	707,078	US$2.2m	0.27%	0.35%
0.74%	Morgan Stanley, Investment Banking and Brokerage Investments	671,311	US$2.1m	20.7%	no data
0.65%	Dafna Capital Management, LLC	589,561	US$1.8m	11.2%	0.49%
0.64%	Northern Trust Global Investments	581,613	US$1.8m	200%	no data
0.52%	Lori Braender	476,992	US$1.5m	0%	no data
0.47%	Bracebridge Capital, LLC	428,571	US$1.3m	0%	0.4%
0.44%	Everstar Asset Management, LLC	400,125	US$1.3m	0%	0.89%
0.43%	A. Toth	388,295	US$1.2m	0%	no data
0.31%	Qube Research & Technologies Ltd	282,431	US$884.0k	-60.7%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/10 09:20
End of Day Share Price	2025/01/10 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aquestive Therapeutics, Inc. is covered by 11 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
James Molloy	Alliance Global Partners
Gary Nachman	BMO Capital Markets Equity Research
Kristen Kluska	Cantor Fitzgerald & Co.